Biotechnology startup Rewrite Therapeutics Inc. has been acquired by Intellia Therapeutics Inc. in a potential $200 million deal that will be a windfall for Rewrite investors. Venture-capital firm Civilization Ventures in 2020 and 2021 led financings totaling $2.1 million in Berkeley, Calif.-based gene-editing startup Rewrite, said Civilization General